Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT06453213 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT06453213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06453213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
Lead sponsor
SK Life Science, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 14, 2024
Completion date
July 9, 2027
Enrollment
49 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

focal onset seizure